Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Glenmark Pharmaceuticals Ltd.
NSE: GLENMARK
|
BSE: 532296
|
ISIN: INE935A01035
|
Industry: Pharmaceuticals
|
Mid-range Performer
1929.3000
-33.30
(
-1.70
%)
NSE
Oct 08, 2025
15:31 PM
51.26% Gain from 52W Low
Volume:
306.7K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Glenmark Pharmaceuticals Ltd.
26 May 2023
1929.30
-1.70%
GLENMARK PHARMACEUTICALS
Hold:
Glenmark Pharmaceuticals Ltd.
by
Geojit BNP Paribas
Target: 638
Recommendation
Target
Geojit BNP Paribas
Glenmark Pharmaceuticals Ltd. is trading
above its 200 day SMA
of 1668.1
More from Glenmark Pharmaceuticals Ltd.
Recommended
Market closes lower, Tilaknagar Ind gets CCI nod to acquire Imperial Blue for Rs 4,150 cr
Trendlyne Marketwatch |
08 Oct 2025, 04:07PM
Five stocks to buy from analysts this week - October 7, 2025
The Baseline |
07 Oct 2025, 04:28PM
Earnings Call Transcript - Q4FY20 for Glenmark Pharmaceuticals
|
29 Jun 2020